Abstract:Background: Hypoxic-ischaemic encephalopathy (HIE) is a major cause of neonatal disability and mortality. Although hypothermia therapy offers some neuroprotection, the recovery of neurological function is limited. Therefore, new synergistic therapies are necessary to improve the prognosis. Mesenchymal stem cell-based therapy is emerging as a promising treatment option for HIE. In this study, we studied the therapeutic efficacy of human placenta-derived mesenchymal stem cells (PD-MSCs) in the HIE rat model and analyzed the underlying therapeutic mechanisms. Methods: Rats were divided into 6 groups (n = 9 for each) as follows: control, HIE model, HIE + normal saline, and HIE + PD-MSC transplantation at days 7, 14 and 28 postpartum. Following PD-MSC transplantation, neurological behavior was evaluated using rotarod tests, traction tests, and the Morris water maze test. The degree of brain tissue damage was assessed by histological examination and Nissl staining. Expression levels of apoptosis-related proteins and inflammatory factors were quantified by Western blotting and enzyme-linked immunosorbent assays. Immunofluorescence was used to investigate the ability of PD-MSCs to repair the morphology and function of hippocampal neurons with hypoxic-ischaemic (HI) injury. Results: PD-MSC transplantation enhanced motor coordination and muscle strength in HIE rats. This treatment also improved spatial memory ability by repairing pathological damage and preventing the loss of neurons in the cerebral cortex. The most effective treatment was observed in the HIE + PD-MSC transplantation at day 7 group. Expression levels of microtubule-associated protein-2 (MAP-2), B-cell lymphoma-2 (BCL-2), interleukin (IL)-10, and transforming growth factor (TGF -β1) were significantly higher in the HIE + PD-MSC treatment groups compared to the HIE group, whereas the levels of BCL-2-associated X protein (BAX), BCL-2-associated agonist of cell death (BAD), IL-1β and tumour necrosis factor α (TNF-α) were significantly lower. Conclusions: We demonstrated that intravenous injection of PD-MSC at 7, 14 and 28 days after intrauterine HI damage in a rat model could improve learning, memory, and motor function, possibly by inhibiting apoptosis and inflammatory damage. These findings indicate that autologous PD-MSC therapy could have potential application for the treatment of HIE.

Human Neural Stem Cell Grafts Modify Microglial Response and Enhance Axonal Sprouting in Neonatal Hypoxic–Ischemic Brain Injury

Human Placenta-Derived Mesenchymal Stem Cells Improve Neurological Function in Rats with Intrauterine Hypoxic-Ischaemic Encephalopathy by Reducing Apoptosis and Inflammatory Reactions

Grafting neural stem cells improve the impaired cognitive deficits and spatial recognition after ischemic- hypoxic brain damage in neonatal rats

Neural Stem Cells Expressing Bfgf Reduce Brain Damage And Restore Sensorimotor Function After Neonatal Hypoxia-Ischemia

Early Transplantation of Human Cranial Bone-derived Mesenchymal Stem Cells Enhances Functional Recovery in Ischemic Stroke Model Rats

Human neural stem cells transplanted during the sequelae phase alleviate motor deficits in a rat model of cerebral palsy

Human neural stem cells rapidly ameliorate symptomatic inflammation in early-stage ischemic-reperfusion cerebral injury

Transplanted Deep-Layer Cortical Neuroblasts Integrate into Host Neural Circuits and Alleviate Motor Defects in Hypoxic-Ischemic Encephalopathy Injured Mice

Highly Efficient Differentiation of Neural Precursors from Human Embryonic Stem Cells and Benefits of Transplantation after Ischemic Stroke in Mice

[Neural Stem Cells and Human Brain Regeneration Medicine].

Human neural stem cell transplantation attenuates apoptosis and improves neurological functions after cerebral ischemia in rats.

In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury

Neuronal cell reconstruction with umbilical cord blood cells in the brain hypoxia-ischemia

[Intracerebral Transplantation of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Neonatal Rat Model of Hypoxic-Ischemic Brain Damage: Protective Effect to Injured Brain].

Therapeutic effects of neural stem cells transplantation on focal cerebral ischemic-reperfusion injury in newborn rat

Transplantation of Rat Embryonic Neural Stem Cells Ameliorates Sensorimotor Deficits Following Neonatal Hypoxic-Ischemic Brain Damage in Rats

Neural Stem-Like Cells Derived from Human Amnion Tissue Are Effective in Treating Traumatic Brain Injury in Rat

Intranasal delivery of human oligodendrocyte precursor cells enhances regenerative effects in premature rat brain following hypoxic–ischemic injury

Transplantation of Induced Neural Stem Cells Derived from Human Fibroblasts Promotes Functional Recovery of Spinal Cord Injury in Rats

Molecular Mechanisms Underlying Effects Of Neural Stem Cells Against Traumatic Axonal Injury

Neural Stem/progenitor Cells Participate in the Regenerative Response to Perinatal Hypoxia/ischemia.